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Endothelial cells comprise the inner lining of the entire circulatory system and are key 
mediators in many aspects of vascular biology.  The interaction of endothelial cells with 
blood-borne constituents and the mechanical forces due to blood flow regulate a broad 
range of diseases that originate at the vasculature.  The challenges of studying endothelial 
cell biology in vivo is that it is highly invasive to access, experimentally manipulate, 
and/or observe changes inside of blood vessels.  Furthermore, current in vitro-based 
systems do not faithfully recreate the mechanical and chemical cellular environments 
with the proper length scales seen in physiology.  Here we show examples of using the 
tools of microfluidics and microfabrication in developing perfusion-based in vitro 
systems that mimic the in vivo environments of endothelial cells.  We describe a novel, 
reconfigurable micro-pumping and valving system that enables the delivery of a wide 
range of mechanical shear stress to multiple endothelial cell compartments 
simultaneously.  We also utilized this pumping and valving system to culture endothelial 
cells under continuous recirculation of sub-microliter amounts of fluid.  Finally, we 
engineered a compartmentalized endothelium to model the intravascular adhesion events 
of circulating cancer cells with endothelium at metastatic and non-metastatic sites.  We 
determined that the endothelium regulates site-specific adhesion of circulating cancer 
cells that is independent of the predicted metastatic abilities of the cancer cells.  
Collectively, these results confirm that microfluidic technology can be used to properly 
 vi
 vii
mimic a broad range of the endothelial cell environments seen in physiology.  
Furthermore, we establish microfluidics as a platform for the development of systems 
that have the capabilities of advancing the understanding of endothelial cell biology as it 





 The vascular endothelium is comprised of a monolayer of endothelial cells that 
lines the interior of blood vessels of the entire circulatory system.  Under normal 
physiology, endothelial cells remain in a quiescent and growth-arrested state which 
originally perpetuated the notion that they served as a passive boundary between blood 
and the surrounding organ environment.1  It is now known that endothelial cells are key 
mediators in many aspects of vascular biology including atherosclerosis2, 3, thrombosis4, 5, 
vascular tone6-8, angiogenesis9, 10, and inflammation11-13.  In turn, these 
pathophysiological conditions that originate at the endothelium directly contribute to the 
progression of many diseases such as heart attack, stoke, high blood pressure, cancer, and 
arthritis.1  Therefore, an understanding of the responses of endothelial cells to its 
physiological environment has a fundamental impact in biology and medicine. 
 
 The challenges to studying endothelial cell behavior in vivo are due in large part 
to the very invasive nature of accessing, experimentally manipulating, and/or observing 
changes in blood vessels.14  In vitro-based systems that mimic either the mechanical7, 15, 16 
or chemical environments17-19 of endothelial cells have contributed greatly to the 
understanding of  endothelial cell biology.  However, these in vitro-based systems are 
typically macroscopic in scale.  Therefore, these systems fail to faithfully recreate the 
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cellular environments representative of the conditions seen in vivo in terms of short 
distances between cells with continuous nutrient supply and waste removal.20  
Microfluidic systems, engineered devices that manipulate small amounts of fluids in 
channels with dimensions of tens to hundreds of microns21, offers the potential to 
improve the current state of the art of in vitro-based systems for studying endothelial cells.  
Microfluidic systems possess the ability to integrate precise fluid actuation22, formation 
of independent cellular compartments for parallel experiments23, and spatial control and 
delivery of biomolecules,24 within the central construct of channels on the size scale of 
small blood vessels such as arterioles or venules.25     
 
 The objective of this thesis research was to develop microfluidic systems 
specifically designed to advance the understanding of endothelial cell biology.  The 
common threads among the research presented in this thesis are:  1) microfluidic systems 
fabricated out of poly(dimethylsiloxane) (or PDMS) using soft lithography26 and 2) 
microfluidic culture and analysis of primary human microvascular endothelial cells.  
Chapter II describes the development of a novel, computer-controlled micro-pumping 
and valving system that enables the delivery of a wide range of mechanical shear stress to 
multiple endothelial cell compartments simultaneously.  The endothelial cells in this 
system demonstrate the characteristic response of alignment and elongation to shearing 
flow16, a result that had not been previously achieved in a self-contained microfluidic 
system.  The work from Chapter III also utilizes the reconfigurable, computer-controlled 
micro-pumping and valving system described in Chapter II but instead demonstrates real-
time imaging of endothelial cell culture under continuous recirculation of sub-microliter 
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amounts of fluid.  Finally, Chapter IV describes a compartmentalized microfluidic 
endothelium for evaluating the intravascular adhesion of metastatic breast cancer cells 
expressing different chemokine receptors onto differentially treated endothelium.  We 
determined that the endothelium regulates site-specific adhesion of circulating cancer 
cells that is independent of the chemokine receptor expression of the cancer cells.   
 
 Collectively, these studies confirm that microfluidic technology can be used to 
properly mimic a broad range of the endothelial cell environments seen in physiology.  
Furthermore, the microfluidic systems described in this dissertation are not just 
miniaturized versions of conventional cell culture techniques.  Instead, they proceed 
beyond the current state of the art of in vitro-based systems by allowing for multiple cell 
culture experiments in parallel, more in vivo-like culture conditions, and new insights into 
the intravascular adhesion steps in cancer metastasis.  Therefore, the described work has 
contributed to establishing microfluidics as a platform for the development of systems 
that have the capabilities of advancing the understanding of endothelial cell biology as it 
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Computer-Controlled Microcirculatory Support System for Endothelial Cell 
Culture and Shearing 
 
Endothelial cells (ECs) lining the inner lumen of blood vessels are continuously subjected 
to hemodynamic shear stress which is known to modify EC morphology and biological 
activity.  This paper describes a self-contained microcirculatory EC culture system that 
efficiently studies such effects of shear stress on EC alignment and elongation in vitro.  
The culture system is composed of elastomeric microfluidic cell shearing chambers 
interfaced with computer-controlled movement of piezoelectric pins on a refreshable 
Braille display.  The flow rate is varied by design of channels that allow for movement of 
different volumes of fluid per variable-speed pump stroke.  The integrated microfluidic 
valving and pumping system allowed primary EC seeding and differential shearing in 
multiple compartments to be performed on a single chip.  The microfluidic flows caused 
ECs to align and elongate significantly in the direction of flow according to their exposed 
levels of shear stress.  This system overcomes the small flow rates and inefficiencies of 
previously described microfluidic and macroscopic systems respectively towards 
engineering the in vivo like environment for the study of EC response to shear stress 
within a microfluidic setting. 
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Introduction 
Microfluidic systems enable for a high level of fluidic control to create in vivo 
like microenvironments for cell culture.1-10  Most microfluidic culture systems to date, 
however, have focused primarily on regulating the chemical environment and not the 
fluid mechanical environment of cells, such as the exposure of endothelial cells (ECs) to 
physiological levels of shear stress (5-20 dyn/cm2).11  The difficulty is due, at least in 
part, to the lack of integrated microfluidic pumps that can sustain high enough levels of 
shear stress in cell culture compatible conditions for the duration of time required (hours 
to days) to observe cellular effects.  Here, we report the use of self-contained, computer-
controlled microfluidic cell culture chamber arrays where high-velocity (max of 3 cm/s) 
pulsatile fluid flows inside high-resistance microchannels generate shear stress levels 
capable of fluid mechanical regulation of EC phenotypes.   
 
ECs comprise the endothelium or the monolayer of cells lining the inner wall of 
blood vessels subjected to hemodynamic shear stress in vivo.  ECs have the property to 
dynamically sense changes in shear stress levels present in their environment.12  The 
responsiveness of ECs to changes in shear stress levels is assessed by modifications in 
morphology including alignment and elongation in the direction of flow,13,14 adaptation 
of cytoskeleton-associated proteins,15 fluctuations in intracellular calcium concentration 
involved with cell signaling,16 secretion of factors necessary for survival,17 and 
expression levels of genes.18  A fundamental question in cardiovascular research is how 
the mechanical forces associated with shear stress are first sensed and then transduced by 
ECs into certain diseased states such as thrombosis19 or atherosclerosis.20  In order to 
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address this question, many cardiovascular researchers model or recreate physiological 
flow conditions in vitro with macroscopic systems utilizing external pumping 
mechanisms, viscometers, and/or fluid reservoirs.13,14,21  Although these systems produce 
well-defined fluid flows to relate shear stress levels with a measurable biological 
response, they are limited due to their consumption of large amounts of reagents, 
potential for contamination, decreased portability, and inability to perform multiple 
experiments simultaneously.  This system addresses the limitations of existing 
macroscopic systems by employing a self-contained, re-circulating 
poly(dimethylsiloxane) (PDMS) microfluidic device with parallel channels interfaced 
with a refreshable array of piezoelectric pins of a commercially available Braille 
display.22  Each piezoelectric pin functions as an actuator for a microfluidic valve when 
its up-and-down movement is used to deform the elastomeric PDMS microchannels.23  
Fluid is pumped through the microchannels using a variable-speed, 3-pin, peristaltic 
sequence.  The valving capabilities of the microarray of Braille pins enable for one-step 
seeding of multiple cell shearing compartments that can then be re-circulated 
simultaneously in parallel but under different cell shearing conditions.  The system 
generates different shear stress levels at the same pumping frequency by varying the size 
of the contact area of the microchannels where the pins press in which allows for 
displacement of different volumes of liquid per pump stroke.  Flow rates sufficient for 
EC shearing are produced by maximizing the size of this contact area such that the 
displacement of fluid is large.  This system concurrently addresses the restricted flow 
rates of microfluidic systems and the inefficiencies of macroscopic systems thereby 
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opening new windows for evaluating the physiological and biological effects associated 
with application of shear stress to ECs in vitro.   
   
Experimental Section 
 
Device Fabrication.  The microfluidic device (Figure II.1a) was fabricated from 
three layers of poly(dimethylsiloxane) (PDMS) formed from prepolymer (Sylgard 184, 
Dow Corning) at a ratio of 10:1 base to curing agent.  The top layer was formed by 
replica molding of the prepolymer against relief features machined from brass and steel 
bars (Figure II.1b) to form fluid reservoirs and cured overnight at 60oC.  The middle layer 
was formed using soft lithography24 to form a layer with negative relief channel features 
~30 μm in height and 300 μm in width.  The positive relief features of the mold were 
composed of SU-8 (Microchem, Newton, MA) formed on a thin glass slide (200 μm 
thick) using backside diffused-light photolithography.23  The glass slide was silanized 
with tridecafluoro-1,1,2,2-tetrahydrooctyl)-1-trichlorosilane (United Chemical 
Technologies Inc., Bristol, PA).  The prepolymer was cured at 60oC overnight and holes 
were punched in it to connect channel features to the culture media reservoir.  The 
negative relief channel features were sealed against a flat thin membrane layer formed by 
spin coating prepolymer onto silanized glass slides and cured at 150oC overnight.  PDMS 
cured at 150oC as opposed to 60oC demonstrates more consistent mechanical properties.25  
The three layers were sealed irreversibly by treating with plasma oxygen (SPI Supplies, 
West Chester, PA) for 30 seconds, pressing the flat surfaces together, and placing in 60oC 
for 5-10 minutes.  Immediately after sealing, sterile phosphate buffered saline (PBS) was 
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injected to maintain the hydrophilic nature of the channels.  Shortly after, the device was 
sterilized by placing under UV light for ~30 minutes. 
 
Fluid Actuation.  A Braille display (DotView DV-1, KGS, Japan) provided a 
grid (32 x 24) of piezoelectric pins (1.3 mm in diameter) that function as an array of 
microfluidic valves and pumps.  The microfluidic device interfaces with the Braille 
display by simply holding the device in place such that the channels align with the Braille 
pins (Figure II.1b) which push upward with a force of 4 cN or approximately 1/100th of a 
pound force (manufacturer’s specifications).  The Braille pins were controlled with a 
computer program written in C++ that manipulates the pins to either remain in the up 
position and act as valves (Figure II.2a) or be components of a 3-pin peristaltic pump that 
actuates fluid in a pulsatile nature (Figure II.2b).  The microfluidic channels were 
designed such that both low shear stress levels (maximum shear stress ~5 dyn/cm2 per 
pump cycle) and high shear stress levels (maximum shear stress ~60 dyn/cm2 per pump 
cycle) can be generated within the same loop by changing the volume displacement per 
pump stroke (Figure II. 2b).  Flows at low and high shear levels were actuated by what 
will be denoted as “small pump” and “large pump” respectively.  The average shear 
stress levels of both the small and large displacement pumps were controlled by changing 
the frequency of the pumping sequence.   
   
Characterization of Fluid Flows.  6 micron diameter fluorescent (Carnine) 
polystyrene microspheres Molecular Probes, Eugene, OR) were tracked using a digital 
CCD camera (Hamamatsu ORCA-ER) and a fluorescence stereomicroscope (Nikon 
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SMZ1500).  Images sequences were acquired at ~15 frames/s to determine the velocity of 
the microspheres which are representative of the fluid velocity and used to determine the 
time-varying fluid flow rate Q(t).  The Womersley number, α, is a dimensionless 
parameter used to describe the pulsatile nature of fluid flow in response to an unsteady 
pressure gradient26 and is defined as: 
 
ν
ωα h=  (1) 
 
where h is the height of the channel (~30 μm), ω is frequency of pumping, and ν is the 
kinematic viscosity.  For the described microfluidic device, α is small (<<1) and thus the 
unsteady effects on shear stress levels are negligible.  For fully developed, steady channel 





6μτ =  (2)  
where μ is the dynamic viscosity, Q is the fluid flow rate, and w is the width of the 
channel (~ 300 μm).  However, since the pulsatile effects on shear stress are negligible, 
the time-varying values of shear stress, τcell(t), can be determined by replacing Q in (2) 
with Q(t).14  The average flow rate and average shear stress levels for the given pump and 
pumping frequency were determined by taking the time-average of the discrete values of 
Q(t) and τcell(t) respectively over one wavelength multiple times and then performing 
statistical analysis to determine the average and standard error of measurement (SEM).  
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General Cell Culture.  Human dermal microvascular endothelial cells 
(HDMECs, Cambrex, East Rutherford, NJ) passage number 7-13 were cultured in 
endothelial growth medium-2 (EGM-2, Cambrex) in T-75 culture flasks (Corning, Acton, 
MA) that were placed in a humidified 5% CO2 cell culture incubator.  The HDMECs 
were collected by washing and detaching with 0.25% Trypsin/EDTA (Invitrogen, 
Carlsbad, CA).  The Trypsin solution was neutralized with 10% FBS in DMEM and spun 
down with a centrifuge (ThermoForma, Marietta, OH) for 5 min, 4o C, 800 RPM.  The 
supernatant was removed and the pellet was resuspended in EGM-2.  The spin and 
resuspension in EGM-2 were repeated to ensure removal of Trypsin which inhibits cell 
adhesion during seeding.   
 
Cell Seeding and Microfluidic Cell Culture and Shearing.  Prior to cell 
seeding, fibronectin solution (Invitrogen) at a concentration of 100 μg/ml in PBS was 
injected along the cell seeding channel to promote cell adhesion.  The fibronectin solution 
was introduced into regions of the microchannels defined by the valves created by the 
Braille display using two 30 gauge insulin needles, one to vent and one to inject.  The 
fibronectin solution coated the channel surface for 30 minutes at 25oC and then was 
rinsed by circulating PBS from the reservoir for 30-60 minutes.  PBS was then replaced 
in the reservoir with EGM-2 to rinse the PBS by circulating for 30-60 minutes.  
Subsequently, the cell solution (~106 cells/ml) was injected into the microchannels in the 
same manner as the fibronectin solution.  After the cells were seeded, the seeding channel 
was valved at locations to form individual cellular compartments to be circulated with 
loops that are pumped independently of each other (Figure II.2a).  The device and Braille 
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display were placed in a 37oC/5% CO2 dry incubator to allow for the cells to attach for 
60-90 minutes.  After the cells attach, culture media was circulated with the small pump 
at the desired pumping frequency to sustain the cells for the next 48-72 hours with the 
culture media in the reservoir being replaced every 24 hours.  Once the cells reached the 
desired level of confluence, the culture media was replaced and remained for the duration 
of the subsequently described experiment.   
 
Two experiments were conducted to compare the effects of varying levels of 
shear stress on cell morphology.  The first experiment compared two compartments 
located within the same device with one circulated with the small pump and the other 
with the large pump and both circulated at the same frequency of 1.0 Hz.  Since both 
compartments were located in the same device, they shared the same culture media.  The 
time-average values of shear stress at a pumping frequency of 1.0 Hz were determined 
with eq 2 to be <1 dyn/cm2 for the small pump and ~9 dyn/cm2 for the large pump.  The 
second experiment compared the changes in cell morphology in three compartments 
located within the same device that were all circulated with the large pump but at 
different pumping frequencies of 0.25 Hz, 0.75 Hz, and 2.0 Hz.  The time-average shear 
stress values were determined with eq 2 to be approximately 3 dyn/cm2 (0.25 Hz), 7 
dyn/cm2 (0.75 Hz), and 12 dyn/cm2 (2.0 Hz). 
 
Quantification of Cellular Alignment and Elongation.  The morphological 
response of ECs to shear stress was measured with angle of orientation and the Shape 
Index (SI) which are commonly used parameters that quantify the extent that the ECs 
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align and elongate in the direction of flow respectively.  Briefly, the angle of orientation 
is defined by the angle formed by the cell’s major axis and the direction of flow where 0 
deg is a cell aligned perfectly with the direction of flow and 90 deg is a cell aligned 
orthogonal to the direction of flow.  The SI is a dimensionless measure of the roundness 





ASI π=  (3) 
 
where A is the area of the cell and P is the perimeter of the cell.  The SI ranges from 0 to 
1 where 0 is a straight line and 1 is a perfect circle.  For cells in static culture, the mean 
angle of orientation is ~45 deg with a large standard of deviation and the mean SI value is 
about 0.8 indicating that the population of cells is randomly oriented and very round in 
shape.14  However, since the cells in the described system are cultured in microchannels 
under flowing conditions with the small pump before they are sheared with the large 
pump, the typical baseline values for angle of orientation (30-40 deg) and SI (0.6-0.7) are 
slightly less and thus indicates that they are slightly more aligned and less round than 
cells in static culture conditions.  
 
EC images were obtained using an inverted phase contrast microscope (Nikon TE 
300) and a digital CCD camera (Hamamatsu ORCA-ER) at 10X magnification.  Images 
were taken at the onset of circulation with the large pump and every 6-12 hours 
thereafter.  The images were analyzed with Simple PCI imaging software program 
(Compix Inc. Cranberry Township, PA) to measure the angle of orientation and the SI of 
 15
individual cells.  This data was then exported to an Excel spreadsheet to determine the 
sample average and the SEM values for angle of orientation and SI for each time frame.  
 
Statistics.  Statistical differences between experimental groups were evaluated 
using two-sample Student t-tests at a 95 percent confidence level assuming unequal 
variances. 
 
Results and Discussion 
 
Characterization of Fluid Flows.  The purpose of this study was to recreate 
pulsatile shear stress levels capable of remodeling ECs within a microfluidic setting.  The 
generation of pulsatile flow is of immense physiological importance because it represents 
the nature of blood flow in the arterial vasculature that produces shear stress levels 
modifying EC morphology.  Since ECs demonstrate the ability to distinguish between 
pulsatile versus non-pulsatile flow,14 in order to be physiologically relevant, the described 
in vitro system must not only generate flow with average shear stress levels seen in vivo 
(5-20 dyn/cm2)11 but deliver it in a pulsatile nature as well.    
The pulsatile flow was characterized by relating the average flow rate to the 
pumping frequency (Figure II.2c).  For the small pump, the average flow rate increased 
linearly (R-squared = 0.99) with pumping frequency and the maximum average flow rate 
achieved was 5.3·10-3 microliters/s at a pumping frequency of 2.0 Hz.  The maximum 
pumping frequency applied for the small pump as well as the large pump was 2.0 Hz 
because pumping frequencies above 2.0 Hz are not commonly present within the blood 
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circulation in vivo.27  As seen with the small pump, the average flow rate for the large 
pump increased linearly with smaller values of pumping frequency.  However, unlike the 
small pump, the average flow rate for the large pump plateaus for pumping frequencies 
larger than ~0.75 Hz (Figure II.2c) reaching a maximum average flow rate of 4.9·10-2 
microliters/s at a pumping frequency of 2.0 Hz.  For smaller values of pumping 
frequencies (<0.75 Hz), the average flow rate for the large pump was ~20 times larger 
than the average flow rate for the small pump.  At a pumping frequency of 2.0 Hz, the 
average flow rate for the large pump was ~10 times larger than the average flow rate for 
the small pump exhibiting a significant plateau effect for increased pumping frequency 
with the large pump.   
 
The plateau effect was only seen with the large pump and indicates reduced 
efficiency in actuating fluid in the forward direction for pumping frequencies above 
~0.75 Hz.  This plateau effect is most likely due to one of the steps in the pumping 
sequence becoming rate-limiting with increased pumping frequency.  
 
EC Morphology Response to Cell Shearing Conditions.  The responsiveness of 
ECs to different levels of shear stress was evaluated in terms of changes in morphology.  
Figure II.3a is a time-lapse comparison between the changes in EC morphology due to 
the small pump (average shear stress <1 dyn/cm2) versus the large pump (average shear 
stress ~9 dyn/cm2) both circulated at a pumping frequency of 1.0 Hz.  The images 
suggest that the morphology of the cells circulated by the small pump at 1.0 Hz remain 
random in orientation and relatively round in shape whereas the morphology of the cells 
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circulated by the large pump at 1.0 Hz progressively align and elongate in the direction of 
flow with time.  Alignment and elongation were quantified in terms of EC angle of 
orientation (Figure II.3b) and SI (Figure II.3c) respectively.  For the small pump, angle of 
orientation decreased 10 deg (values given for changes in angle of orientation and SI are 
approximate) from T = 0 h and T = 6 h but did not change significantly after T = 6 h 
(p>0.05).  The decrease in angle of orientation from T = 0 h to T = 6 h was not expected 
and is considered a measurement artifact based on results from previous experiments.  
Thus, for the small pump, neither the angle of orientation nor the shape index (SI) for the 
ECs changed significantly from T = 0 h to T = 24 h (p>0.05).     
 
For the large pump, both angle of orientation and SI decreased significantly 
(p<0.0001) from T = 0 h to T = 24 h.  The ECs cultured with the large pump exhibited a 
decrease in angle of orientation by 20 deg and a decrease in SI by 0.21 from T = 0 to T = 
24 h.  The percent decrease from T = 0 to T = 24 h for angle of orientation and SI were 
57% and 32% respectively.  There was also a substantial decrease in the standard of 
deviation of the angle of orientation from T = 0 h to T = 24 h which is characteristic of 
EC alignment in the direction of flow.14  Furthermore, the angle of orientation and the SI 
values were significantly different than the values for the small pump at T = 24 h 
(p<0.0001).  In agreement with previous studies, EC elongation occurred more rapidly 
than alignment under cell shearing conditions (Figure II.3b and II.3c).28  In addition, the 
cell density remained steady between 400-550 cells/cm2 for both experiments for the 
duration of the experiment demonstrating that cell detachment was not an issue for the 
given pumping conditions (data not shown).   
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The morphological response of the ECs validate that this in vitro model system is 
capable of generating shear stress levels sufficient enough to modify EC phenotypes.  
The average shear stress levels were altered by changing the amount of fluid 
displacement per pump stroke at a constant pumping frequency.  In addition, it is possible 
to vary the average shear stress levels by changing the pumping frequency while keeping 
the amount of fluid displacement per pump stroke constant.  Figure II.4 shows results 
from a single chip three-loop experiment where each loop of ECs were exposed to flow 
generated by large pumps but the average shear stress was varied by changing the 
pumping frequency.  Average shear stress levels ranging from ~2.5 dyn/cm2 to 12 
dyn/cm2 were generated by varying the pumping frequency between 0.25 and 2 Hz.  All 
flow conditions exhibited the ability to significantly modify EC morphology in terms of 
alignment and elongation (p<0.0001).  It has been shown previously that it is the average 
shear stress that is the primary factor that regulates the relative timing of EC alignment 
and elongation.21  The results of the multiple cell shearing experiment support those 
previous outcomes.  
 
The described microfluidic system has five characteristics that make it 
advantageous over existing macroscopic systems used to study EC response to shear 
stress.  (i) One-step seeding of cells into multiple compartments.  (ii) Re-circulation of 
cell culture media from a single reservoir only ~1 ml in volume.  (iii) Cells and reagents 
once placed within the device remain there indefinitely.  (iv) Multiple culture loops 
whose pulsatile fluid flows are actuated independently of each other.  (v) System remains 
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portable enough to be placed entirely within a cell culture incubator.  The combination of 
these characteristics address the limitations of macroscopic systems such as consumption 
of large amounts of cells and reagents, potential for contamination, decreased portability, 
and inability to efficiently perform multiple pulsatile flow experiments in parallel.  This 
current device is restricted in its range of average shear stress levels that it can generate 
(up to ~12 dyn/cm2) which does not encompass the entire range of average shear stress 
levels seen physiologically (5-20 dyn/cm2).11  The system, however, to our knowledge is 
the first one of its kind that produces shear stress levels that align and elongate ECs with 
pulsatile fluid flow and hence demonstrates the ability to create an arterial-like 





  We present the foundation for an in vitro microfluidic cell culture system that 
recreates physiological conditions present in the EC environment in vivo in terms of shear 
stress levels and pulsatile flow patterns.  Pulsatile flow is essential for this system to be 
physiologically relevant because ECs have the marked ability to discriminate between 
pulsatile and non-pulsatile flow.14  The generation of pulsatile flow was accomplished by 
integrating the elastomeric channels of the microfluidic device with an array of Braille 
pin actuators to create a 3-pin peristaltic pump.  Previously described microfluidic 
systems3,22 are limited in their capacity in generating high enough levels of shear stress 
necessary for EC remodeling.  This system overcomes these limitations by designing the 
microfluidic channels to maximize the volume displacement per Braille pin actuation.  
Efficiency not present in macroscopic systems is intrinsic to this design because the 
microarray of pin actuators coupled with elastomeric channels enables one-step seeding 
of multiple cell shearing chambers, followed by compartmentalization of the chambers 
into separate circulation loops, and simultaneous culture of ECs in the different 
compartments under different shear stress conditions.  Furthermore, the flexibility of the 
design should allow for ready incorporation of additional analytical components.  This 
marks a significant step in creating a fully-integrated microfluidic device capable of 
providing greater insight into the mechanisms involved with mechanotransduction of 
signals associated with shear stress that regulate EC phenotype.   
Figure II.1.  Microfluidic device for EC culture and shearing.  (a) Photograph of the 
device.  (b) Three-dimensional schematic depicting the three-layer device fabrication 
placed on top of a grid of Braille pins.  The approximate thickness of the top, middle, and 
bottom layers are 1 cm, 1 mm, and 100-200 μm respectively.  The top layer contains two 
reservoirs: one to house cell culture media (‘culture media reservoir’) to be circulated and 
the other containing water (‘evaporation reservoir’) to assist in preventing evaporation 
within the microfluidic channels.  The volume of both reservoirs is ~1 ml.  The bottom 
layer serves as a thin membrane that provides the interface between the Braille pins and 





Figure II.2.  Demonstration of the microfluidic valves and pumps for cell culture.  (a) 
Close-up of cells attached within an individual cellular compartment.  The individual 
compartments are created by the Braille pins acting as valves which are depicted by the 
dark circles along the horizontal region of the channel.  Each compartment is circulated 
by flow loops that actuate fluid independently of each other.  Fluid in each flow loop can 
be actuated either clockwise by the small pump (dashed curved line and arrows) or 
counterclockwise by the large pump (solid curved line and arrows).  Cells shown were 
cultured under cell shearing conditions for 12 h.  (b) Step-wise depiction of the peristaltic 
pumping sequence comparing the small pump and large pump.  Fluid is actuated through 
the channels in a pulsatile nature via a 3-pin, repeating 4-step peristaltic pumping 
sequence.22  In this particular pumping sequence, it is Step 2 or the step where the middle 
pin of the 3-pin pump moves from the down to the up position that drives most of the 
fluid in the forward direction.  The other steps in the pumping sequence prime the pump 
to maximize volume displacement during Step 2.  Increased shear stress levels are 
generated by the large pump by increasing the area of the channel that is positioned over 
the middle pin of the 3-pin pump reaching a maximum width equal to approximately the 
diameter of the Braille pin (1.3 mm).  The pair of auxiliary dead-end channels that run 
parallel to fluidic channels act as void spaces to assist in deformation based actuation due 
to the Braille pins.  These void space channels are of the same height as the fluidic 
channels due to them being fabricated concurrently during the backside diffused-light 
lithography process.23  (c) Comparison of pumping capabilities of small pump and large 
pump.  The average flow rate (microliters/s) for the small pump (■) and the large pump 
(♦) were plotted against the pumping frequency (Hz).  Error bars represent SEM (note: 
some of the values for SEM are at a value so small that the error bars do not extend 








Figure II.3.  Cell morphology response to cell shearing conditions.  (a) Time-lapse 
images comparing changes in cell morphology between small and large pumps circulated 
at the same pumping frequency (1.0 Hz).  Quantification of cell alignment (b) and 
elongation (c) comparing the EC response due to circulation in one loop by the small 





Figure II.4.  Morphological response of cells subjected to different levels of cell shearing 
conditions.  Quantification of cell alignment (a) and elongation (b) comparing EC 
response in three loops due to circulation by the large pump circulated at frequencies of 
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Quantitative Real-time Imaging of Evaporation-mediated Responses of Endothelial 
Cells Under Sub-microliter Recirculation Culture  
Compared to conventional cell cultures performed in Petri dishes with low cell 
volume to extracellular fluid volume (CV/EV) ratios, microfluidic environments with 
large CV/EV ratios have many advantages in terms of cellular self-conditioning of their 
surrounding medium.1  Systems with large CV/EV ratios, however, typically also possess 
large surface to volume (SAV) ratios which increases the rate of evaporation and presents 
a challenge, particularly when using microfluidic devices made of water vapor permeable 
materials such as poly(dimethylsiloxane) (PDMS).  Although understanding and 
preventing evaporation is generally important for microfluidic applications, it is 
particularly crucial for sensitive mammalian cell culture applications where even 
relatively small shifts in osmolality can drastically alter cell behavior.2-6  Here we provide 
a practical solution that is demonstrated specifically for human dermal microvascular 
endothelial cell (HDMEC) culture in microfluidics by utilizing a PDMS-parylene-PDMS 
“hybrid” membrane.  These membranes can prevent such evaporation to enable long-term 
culture (~12h) of HDMCs under continuous recirculation of sub-microliter amounts of 
fluid while also providing the mechanical flexibility needed to be compatible with 
deformation-based microfluidic actuation systems and the optical clarity needed for cell 
imaging.  We also have expanded the capabilities of this system to include real-time 
imaging of cellular response in the compartment of interest by customizing the actuation 
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system7 to fit on the stage of an inverted phase contrast microscope.  The ability to 
stabilize evaporation in PDMS chips compatible with pin actuator-based computer 
controlled pumps and valves using the PDMS-parylene-PDMS “hybrid” membrane 
expands the ability to perform convenient and versatile microfluidic cell culture 
experiments where fluid circulation and exchange can be regulated to mimic the dynamic 




Parylene deposition. For parylene coated PDMS, 2.5 or 5μm thick layer of 
parylene C was deposited on the backside of PDMS membranes by using a PDS 2010 
labcoater (Specialty Coating Systems) after covering the well side with a PDMS 
membrane.  
 
Device Fabrication for Microfluidic Endothelial Cell Culture.  The 
microfluidic device for endothelial cell (EC) culture was fabricated as was described 
previously.8  Briefly, three layers of cured poly(dimethylsiloxane) (PDMS) at a ratio of 
10:1 base to curing agent were sealed together irreversibly using plasma oxidation (SPI 
supplies, West Chester, PA).  Unless stated otherwise, the PDMS layers were cured 
overnight at 60oC.  The top of the three layers (~1 cm thick) contains a rectangular 
shaped fluid reservoir (Figure 6a).  The middle layer (~1 mm thick) consists of bell-
shaped channels features9 ~30 μm in height and 300 μm in width formed using soft 
lithography.10  The channel features of the middle layer face downward and are sealed 
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against a thin membrane bottom layer which is the substrate for cell attachment.  PDMS-
only thin membranes were fabricated by spin coating freshly mixed 1:10 PDMS onto 
silanized (75 x 50 mm, 1mm thick) glass slides (Corning Glass Works, Corning, NY) to a 
uniform thickness of either ~120 and 400 μm and then cured overnight at 120oC.  For 
experiments involving parylene coated membranes, the same PDMS-parylene-PDMS 
hybrid thin membrane described above with a total uniform thickness of 200 μm was 
used.   
 
Fluid Actuation System.  The computer-controlled Braille display fluid actuation 
scheme is based on a design described previously7 with minor modifications to make the 
system more compatible with inverted phase contrast microscopy.11   The Braille display 
used (SC9; KGS, Saitama, Japan) was powered by a universal serial bus (USB) and 
consisted of 8 actuation cells, each containing 8 piezoelectric Braille pins (8 × 8 = 64 
pins).   
 
Indium tin oxide (ITO) Heater. The ITO heater was constructed by an ITO layer 
deposited on a glass slide with metallic films for electric contact.  First, the glass slide 
was masked using scotch tape to form the pattern for the ITO layer.  An ITO with a 
thickness of ~1500Å was coated on a 75x25x1 mm slide glass using radio frequency 
sputtering (Enerjet Sputter) as shown in Figure III.1.  This is followed by removing the 
masking tapes and annealing the device in a 650oC convection oven for 1 hour.  The 
resulting sheet resistance of the annealed ITO layer is ~30 Ω/square.  In order to 
smoothly generate electric current through the ITO layer for uniform joule heating,two 
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aluminum strips (1 mm width and 2000Å thick) were patterned and coated in a similar 
manner on two edges of the ITO layer.  Electrical wires were attached to the aluminum 
stripes using silver epoxy glue to form connections to external control circuits.  A 
commercially available wire thermocouple (5TC-TT-J; Newport, Santa Ana, CA) was 
attached onto the heater surface for temperature sensing.  All the wires were connected to 
a microprocessor based temperature control unit (CT16A2088, Minco Products, Inc., 
Minneapolis, MN) for feedback control of the heater surface temperature.  As a result, the 
heater surface can be maintained constantly at desired temperature. The advantages of 
this ITO heater are: 1) excellent optical transparency in visible light wavelength range, 2) 
less image distortion than thin film heater.7, and  3) more uniform heating over large 
areas.   
 
General Endothelial Cell Culture.  Human dermal microvascular endothelial 
cells (HDMECs, Cambrex, East Rutherford, NJ) were cultured in endothelial growth 
media-2 MV (EGM-2 MV, Cambrex) in T-25 culture flasks (Corning, Acton, MA) that 
were placed in a humidified 5% CO2 cell culture incubator.  The HDMECs were 
collected by washing and detaching with 0.25% Trypsin/EDTA (Invitrogen, Carlsbad, 
CA). The Trypsin solution was neutralized with 10% FBS in DMEM and spun down with 
a centrifuge (ThermoForma, Marietta, OH) for 5 min, 4o C, 800 RPM. The supernatant 
was removed and the pellet was resuspended in EGM-2 MV. The spin and resuspension 




Cell Seeding and Microfluidic Cell Culture.  To facilitate cell attachment, the 
channels were coated for 30-60 min at room temperature with 5-10 μl of human plasma 
fibronectin (FN) solution (Invitrogen) at a concentration of 100 μg/ml PBS shortly after 
plasma oxidation (5-10 min).  The FN solution was introduced through holes punched 
with a dermal biopsy puncher (Miltex Inc., York, PA) though the top and middle layer 
prior to sealing with plasma oxidation to act as seeding ports by being compatible for use 
with micropipette tips.  After cell seeding (described below), the seeding ports were 
covered with a sterilized glass slide to avoid contamination when present in non-sterile 
conditions.  After coating, the FN solution was rinsed for 10 minutes with PBS that was 
pumped through the channels from the fluid reservoir.  Afterwards, the device was 
sterilized by placing under UV light for ~30 minutes.  Following UV sterilization, PBS 
was replaced with endothelial growth media-2 MV (EGM-2 MV, Cambrex, East 
Rutherford, NJ) which is supplemented as a kit prior to use with 5% fetal bovine serum 
(FBS) and a host of growth factors/supplements such as vascular endothelial growth 
factor (VEGF).  EGM-2 MV was circulated overnight for the serum proteins to coat the 
PDMS surface along with FN to facilitate cell attachment.  All reagents were added under 
sterile conditions.   
 
A small amount (3-5 μl) of a dense (~107 cells/ml) HDMEC suspension was 
pipeted into the cell seeding port and introduced into fluidic regions defined by the 
Braille pins acting as valves via gentle application of positive pressure.  After the 
HDMECs were seeded, all channels were valved to trap the cells and the PDMS chip and 
the Braille display were placed in a 37oC/5% CO2 incubator to allow for the cells to 
 34
attach for 60-90 minutes.  After the cells attach, EGM-2 MV culture media was circulated 
from the fluid reservoir for the next 24-72 h until the cells reach confluence.   
 
Recirculating Fluid Actuation.  Experiments conducted with recirculation of 
small amounts of fluid (~500 nl) were conducted on the stage of an inverted microscope 
(Nikon TS-100F, Japan), imaged with a 10x Ph1 objective (Achromat), and recorded 
using Coolsnap CF2 Camera with MetaVue software.  To account for the lack of 
controlled temperature and 5% CO2 tension provided by a cell culture incubator, the 
bottom of the PDMS device was heated to 37oC (ITO heater, PID Temperature 
Controller, Minco, Minneapolis, MN) and the culture media was specially formulated 
with a synthetic buffer to maintain stable pH of ~7.3 under ambient conditions.7   
 
Braille pins were reconfigured via computer-control such that flow can only occur 
in the recirculation loop (Figure III.2a) due to complete valving.  The initial amount of 
fluid continuously recirculated was ~500 nl at a pumping frequency of 0.125 Hz.  Images 
were recorded at the intersection of the “X” towards the center of the microfluidic device 
(Figure III.2a).  The cell density was recorded for discrete time points and normalized to 
the value at T=0.  Cells were considered still alive if they remained attached and were 
still moving (visualized with real-time microscopy). For PDMS-only membranes, two 
experiments were performed in duplicates; for the Parylene membrane device, only one 




Results and Discussion 
 
Endothelial Cell Survival Under Recirculating Fluid Actuation.  Using the 
deformation-based fluid actuation described above that incorporates a PDMS-parylene-
PDMS hybrid membrane, we also tested sub-microliter recirculating culture of human 
dermal microvascular endothelial cells (HDMEC) in a non-humidified environment with 
on device heating.  This type of capability is expected to be important for future studies 
of the effect of autocrine and paracrine effects on endothelial cells under fluid perfusion 
conditions. 
 
Confluent monolayers of HDMECs were seeded and cultured within the 
microfluidic device and imaged at the intersection of the “X” region (Figure III.2a).  
Figure III.2b is a timelapse comparison of HDMEC survival under continuous 
recirculation of ~500 nl of media with deformation-based Braille fluid actuation.  The 
experimental conditions were 120 μm thick, PDMS-only membrane (“thin PDMS”); 400 
μm thick, PDMS-only membrane (“thick PDMS”); and 200 μm thick, PDMS-parylene 
hybrid membrane (“hybrid”).  At T = 40 (time given in min), virtually all the cells in the 
visualized region for the “thin PDMS” membrane are dead and detached whereas the 
cells for the “thick PDMS” and “hybrid” membranes remain confluent.  At T = 80, 
virtually all the cells for the “thin PDMS” and “thick PDMS” membranes are dead and 
detached whereas the “hybrid membrane” still remains confluent.   
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The results were quantified by counting the changes in cell density with time due 
to continuous recirculation (Figure III.2c).  For the “thin PDMS” membrane, about 50 
percent of the cells were dead and detached by about T = 25 (extrapolating from data in 
Figure III.2c) and all of the cells were gone by T=50.  For the “thick PDMS” membrane, 
about 50 percent of the cells were dead and detached by T = 65 and all of the cells were 
gone by T = 90.  With the “hybrid” membrane, cells survive much longer under 
continuous recirculation than the PDMS-only membranes.  Cells remain roughly 
confluent (>85 percent of the original cell density) up to T = 720 (or 12h).  Afterwards, 
cells begin to die more rapidly with 50 percent of the cells remaining alive and attached 
at about T=800 (13.3h) and less than 5 percent at T = 1080 (18h) (Figure III.2c).  By 
comparing the times it takes for 50 percent of the cells to die, we conclude that cells are 
able to survive about 2.6 times longer with the “thick PDMS” membrane compared to the 
“thin PDMS” membrane.  In addition, cells are able to survive about 29 times as long 
with the “hybrid” membrane when compared with the “thin PDMS” membrane and 11 
times as long when compared with the “thick PDMS” membrane.  Thus, the integration 
of parylene in the “hybrid” membrane substantially increases the time HDMECs survive 
under continuous recirculation of ~500 nl of fluid even though at 200 μm, the “hybrid” 
membrane is slightly thicker than the “thin PDMS” membrane (120 μm) and half as thick 








Compared to conventional cell cultures performed in Petri dishes with low cell 
volume to extracellular fluid volume (CV/EV) ratios, microfluidic environments with 
large CV/EV ratios have many advantages in terms of cellular self-conditioning of their 
surrounding medium.1  Systems with large CV/EV ratios, however, typically also possess 
large surface to volume (SAV) ratios which increases the rate of evaporation and presents 
a challenge, particularly when using microfluidic devices made of water vapor permeable 
materials such as PDMS.  Although understanding and preventing evaporation is 
important for microfluidic applications generally, it is particularly crucial for sensitive 
mammalian cell culture applications where even relatively small shifts in osmolality can 
drastically alter cell behavior.  Our study provides the following conclusions: 1) under 
non-humidified conditions with heating, both the 120μm- and 400μm–PDMS bottom 
membranes limit HDMEC survival to 25-65 minutes, and 2) PDMS-parylene-PDMS 
“hybrid” membranes can prevent such evaporation while also providing the mechanical 
flexibility needed to be compatible with deformation-based microfluidic actuation 
systems and the optical clarity needed for cell imaging.   
 
The better quantitative understanding of how the osmolality of cell culture media 
changes in PDMS devices may be useful in accounting for and remedying such shifts in 
culture or for application where changes in the osmolality of media in a controlled 
manner during culture is necessary.12  The ability to stabilize evaporation in PDMS chips 
compatible with pin actuator-based computer controlled pumps and valves using the 
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PDMS-parylene-PDMS hybrid membrane expands the ability to perform convenient and 
versatile microfluidic cell culture experiments where fluid circulation and exchange can 
be regulated to mimic the dynamic culture environments in vivo or to manipulate reagents 
for long-term on-chip assays. 
 
 
         













Figure III.1.  Schematic representation of Braille display-based microfluidics. A typical 
design for Braille display-based microfluidics is composed of two layers: Upper bulk 
PDMS with microchannel and bottom membrane. To test the suitability of the parylene 
coated PDMS with Braille displays, bottom membrane consists of three layers: 100μm-
PDMS, 2.5μm-parylene and 100um-PDMS. For cell culture an ITO heater, composed of 
a glass slide with ITO thin film (thickness about 1500Å) and aluminum electrodes 
(thickness about 2000Å) patterned on top of it, is placed underneath the membrane.   
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Figure III.2.  Microfluidic device for HDMEC culture with recirculation. (a) View from 
the top schematic depicting the location of the Braille pins used for valving and pumping, 
microfluidic channels, and fluid reservoir. The fluid reservoir has a total volume of ~1 ml 
and completely surrounds the channel features like a picture frame to provide an 
unobstructed view of the cells seeded within the channels.  Cut-away view shows the 
location of cells seeded towards the center of the device and recirculation loop with 
images recorded at the intersection of the “X.”  (b) Qualitative data showing effects of 
evaporation on cell viability.  Timelapse images for the three experimental conditions for 
thin membrane: 120 micron, PDMS-only (“thin PDMS,” ○), 400 micron, PDMS-only 
(“thick PDMS” □) and 200 micron, PDMS-parylene hybrid membrane (“hybrid” ◊).  
Time listed is in minutes. (c) Quantitative data describing effects of evaporation on cell 
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Chapter IV 
 
Engineered Compartmentalized Microfluidic Endothelium for Studying the  
Intravascular Adhesion of Metastatic Breast Cancer Cells 
 
 
The ability to properly model the intravascular steps in metastasis is essential in 
identifying key physical, cellular, and molecular determinants that can be targeted 
therapeutically to prevent metastatic disease1-4.  Research on the vascular 
microenvironment has been hindered by challenges in studying this compartment in 
metastasis under conditions that reproduce in vivo physiology while allowing facile 
experimental manipulation.  Here we present a compartmentalized microfluidic 
vasculature system to model interactions between circulating cancer cells with vascular 
endothelium at potential sites of metastasis.  The microfluidic vasculature is designed to 
produce spatially-restricted stimulation with pro-inflammatory cytokines, chemokines, or 
chemokine receptor inhibitors that model organ-specific localization of specific 
signalling molecules in vivo under variable flow conditions.  Using this system to 
produce selective stimulation with CXCL12, a chemokine strongly implicated in 
metastasis5-8, we established that activated endothelial cells confer site-specific adhesion 
of circulating cancer cells independent of CXCR4 or CXCR7 receptors on tumor cells.  
This combination of microfluidic technology with cancer biology provides a unique 
physiologic system to reproduce the intravascular microenvironment in metastasis and 
elucidate new cellular and molecular targets for cancer therapy. 
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 Metastatic disease is the cause of death in approximately 90% of patients with 
solid tumors9, emphasizing that preventing and/or effectively treating metastases is the 
primary obstacle to curing cancer.  Trafficking of cancer cells through the circulation and 
arrest of these cells at secondary sites are obligatory steps in metastasis.  Specific 
molecular interactions between circulating cancer cells and vascular endothelium are 
proposed to control organ-specific patterns of metastasis for breast10, lung8, and other 
common solid cancers11, but our knowledge of these signals is lacking.  In particular, the 
chemokine CXCL12 is proposed to promote tropism of malignant breast7, lung8, and 
other cancer cells for characteristic sites of metastatic disease, which has been attributed 
predominantly to signalling through the receptor CXCR4 on cancer cells.  However, 
mechanisms of action for CXCL12 in metastasis also may be regulated through CXCR4 
on vascular endothelium12 and/or CXCR713, a newly identified second receptor for 
CXCL1214.   
 
Here, we present a systematic study using a compartmentalized microfluidic 
vasculature together with genetically engineered cancer cells to establish effects of 
CXCR4 versus CXCR7 on both the endothelium and cancer cells.  The results show that 
with compartmentalized extravascular stimulation of the endothelium, activation of 
CXCR4 and possibly CXCR7 on endothelial cells can play significant roles in promoting 
cancer cell adhesion regardless of presence of these receptors on cancer cells.  These 
results clarify the role of CXCL12 in the intravascular steps of metastasis and provide 
insights for identifying therapeutic targets to block metastasis.  The results also highlight 
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the versatility and utility of the microfluidic vasculature system to enable studies, such as 
compartmentalized extravascular stimulation of select regions of an endothelium, that 
would be too complex, non-physiological or too expensive to perform using conventional 
in vivo 15, 16 or in vitro assay systems.   
 
The microfluidic vasculature is comprised of two poly(dimethysiloxane) (PDMS) 
layers sandwiching a thin, porous, and optically clear polyester membrane (Fig. 1a).  The 
top PDMS layer features a channel with a funnel–shaped inlet that intersects regionally 
distinct, perpendicularly-oriented channels in the bottom PDMS layer (Fig. 1b, c).  The 
top channel (60 μm height, 800 μm width) contains a confluent monolayer of human 
dermal microvascular endothelial cells (HDMECs) (Fig. 1e) cultured on a thin polyester 
membrane with 400 nm pores that permits the transport of biomolecules but not cells 
between the top and bottom channels.  The regions of the top channel that intersect one of 
the bottom channels (60 μm height) are referred to as either the upstream or downstream 
compartment (Figs. 1c-e), depending on the location relative to the funnel-shaped inlet.  
The region between the upstream and downstream compartments with no lower channel 
is referred to as the middle compartment.  The dimensions of each compartment are 4400 
μm (or 4.4 mm) long by 800 μm wide.   
 
Endothelial cells in the upstream and downstream compartment can be region 
selectively treated with biomolecules from the lower channels.  We observed that staining 
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of a confluent endothelium with Syto 64 remains well-defined within the desired 
compartments for at least 5.5 hours (Fig. 1d).  Furthermore, we observed statistically 
greater adhesion of circulating MDA-MB-23117 (or 231-control) breast cancer cells onto 
the endothelial compartment treated with the pro-inflammatory cytokine TNF-α 
compared to the untreated endothelial compartment at shear stress levels of 0.50 dyn/cm2 
and 2.50 dyn/cm2 (Fig. 1 f-h) (p < 0.02).  The spatial control afforded by the system 
enabled direct comparison of cancer cell adhesion onto stimulated versus non-stimulated 
regions of endothelium.   We note that in our system, the shear stress levels of 0.50 
dyn/cm2 and 2.50 dyn/cm2 correspond with flow velocities of 0.2 mm/s and 1.0 mm/s 
respectively.  These velocities are in line with the in vivo blood flow velocity range of 
0.1-1.5 mm/s reported in the microcirculation of potential sites of breast cancer 
metastasis18-20  In addition, integrins on the surface of circulating cells are reported to 
optimally mediate adhesion onto endothelium at shear stress levels below 0.5 dyn/cm2 
with the avidity decreasing rapidly with higher shear stress levels 21.  .   
We utilized the ability to region selectively stimulate the endothelium in our 
microfluidic system to recreate the local stimulation with CXCL12 of tissues that are 
common sites for metastatic breast cancer in vivo7.  The experiments address an under-
studied topic on how CXCL12 and receptors CXCR4 and CXCR7 on vascular 
endothelium, rather than on cancer cells, may be key determinants in the intravascular 
adhesion step of metastasis.  CXCL12 signaling in endothelium is known to upregulate 
and activate adhesion molecules, promoting stable interactions with circulating cells22.  
We specifically characterized the responses of the described endothelial cells (HDMECs) 
to CXCL12 and TNF-α.  These cells are isolated from skin, a tissue with low metastatic 
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potential for breast cancer10, and facilitate low amounts of adhesion of cancer cells under 
unstimulated conditions23.  Under basal culture conditions, HDMECs express low levels 
of CXCR4 and no CXCR7 mRNA (Fig 3a).  When treated with CXCL12 (100 ng/ml, 5h) 
HDMECs increase expression of CXCR4 but continue to not express CXCR7.  When 
treated with TNF-α (50 ng/ml, 5h), relative to basal conditions, endothelial cells increase 
expression of CXCR4 and also express CXCR7.  CXCL12 initiates signaling in 
HDMECs as evidenced by activation of AKT (Fig. 2b), a known downstream effector of 
CXCR424 and potentially CXCR725.  
 
Next, we evaluated how CXCL12 and TNF-α stimulation of HDMECs 
independently or cooperatively modulate adhesion of 231-control breast cancer cells onto 
the endothelium.  We compared the following combinations:  1) CXCL12 only, 2) 
CXCL12+AMD3100 (a competitive inhibitor of CXCR426), 3) CXCL12 + TNF-α, 4) 
CXCL12 + TNF-α + AMD3100, and 5) TNF-α only (Fig. 2c, d).  The levels of 231-
control breast cancer cell adhesion onto the five different treatment conditions  were 
significantly different (p < 0.05) for both the 0.50 dyn/cm2 and 2.50 dyn/cm2 flow 
conditions (Fig. 2c, d).  Conversely, the levels of cancer cell adhesion onto the five 
corresponding untreated endothelium were statistically the same (p > 0.85) for both flow 
conditions.  With the exception of the CXCL12+AMD3100 condition, adhesion of 231-
control cancer cells was significantly greater onto each of the treated compartments than 
onto the corresponding untreated compartments  for both flow conditions (Fig.2c, d) (p < 
0.05).  Treatment of endothelium with both CXCL12 + TNF-α produced additive 
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increases  in adhesion of circulating 231-control cells relative to CXCL12 only and TNF-
α only treated endothelium under both flow conditions (Fig. 3c, d).  These results suggest 
that each cytokine enhances cancer cell adhesion through independent mechanisms.   
 
To determine to what extent effects of CXCL12 on endothelium are mediated 
through CXCR4, we used AMD3100, a specific inhibitor of CXCL12 binding to CXCR4 
but not CXCR7.  When added to the downstream compartment, AMD3100 completely 
blocked CXCL12-dependent increases in cancer cell adhesion to stimulated endothelium 
under 0.50 and 2.50 dyn/cm2 flow conditions (Fig. 2c, d) (p < 0.05).   Adding AMD3100 
to CXCL12 and TNF-α also decreased adhesion of 231-control cells by a comparable 
percentage as the combination of AMD3100 and CXCL12 alone (Fig. 2c, d), suggesting 
that AMD3100 was selectively blocking adhesion mediated solely through CXCL12 but 
not TNF-α (p < 0.05).  Collectively, these data with the specific chemical probe 
AMD3100, combined with absence of CXCR4 in 231-control cells (Fig. 3a), indicate that 
CXCL12 signals through endothelial CXCR4 to promote adhesion of circulating breast 
cancer cells. 
 
Previous reports have shown that CXCR4 expression in cancer cells promotes 
metastasis to distant organs such as the lung7, 27 and that CXCR7 expression in cancer 
cells enhances adhesion onto endothelium under static conditions14.  We compared the 
231-control cells to other MDA-MB-231 cells stably co-expressing GFP with either 
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CXCR4 (231-CXCR4) or CXCR7 (231-CXCR7) (Fig. 3a) to assess the role of these 
CXCL12 chemokine receptors on cancer cells in mediating adhesion onto endothelium 
under flow.  The level of adhesion of all three cancer cell-types onto CXCL12 treated 
endothelium was significantly greater than onto the corresponding untreated endothelium 
under 0.50 dyn/cm2 flow conditions (p < 0.05) (Fig. 3b).  Comparing the three different 
cancer cell lines, adhesion of 231-CXCR4, 231-CXCR7, and 231-control cells was 
statistically different onto both the CXCL12 treated and the untreated endothelium (p < 
0.01).  Comparing pairwise, adhesion of the 231-CXCR4 and 231-CXCR7 cells was 
statistically greater than the 231-control cells on both the CXCL12 and untreated 
endothelium (p < 0.05).  However, median ratios of cells adhering onto the CXCL12 
treated endothelium relative to untreated endothelium were 1.9, 1.9, and 2.1 for the 231-
CXCR4, 231-CXCR7, and 231-control cells, respectively (Fig. 3c).  These ratios are 
statistically the same among the cell lines (p = 0.83).  Therefore, although CXCR4 or 
CXCR7 expression in breast cancer cells facilitates adhesion onto endothelium, the 
enhancement of adhesion due to CXCL12 stimulation of the endothelium was 
comparable for all three cancer cell-types and independent of expression of CXCR4 or 
CXCR7 on cancer cells.  
 
Herein we have described a microfluidic system that models, in a compact format, 
serial interactions of circulating cancer cells with vascular endothelium at metastatic and 
non-metastatic sites. The system represents advancement over previously described in 
vitro assay systems in that it possesses a unique blend of:  1) prolonged, basally 
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originating CXCL12 stimulation of vascular endothelium that models both the high levels 
and directionality of this chemokine characteristic of target organs for metastatic breast 
and many other cancers7; 2) compartment specific stimulation enabling direct comparison 
of cancer cells adhesion onto endothelium of differing metastatic potential within the 
same experiment; and 3) physiologically-relevant flow conditions in micron-scale 
channels.   
 
Using this system, we demonstrate that CXCL12 stimulation of HDMECs enhances 
adhesion of circulating breast cancer cells, regardless of expression of chemokine 
receptors CXCR4 or CXCR7 on the cancer cells.  These results indicate that responses of 
vascular endothelium to the surrounding molecular environment contribute substantially 
to intravascular adhesion of cancer cells, a phenomenon difficult to address with in vivo- 
studies.   We also show that CXCR4 or CXCR7 on breast cancer cells promotes 
intravascular adhesion throughout the channel, supporting a mechanism through which 
these receptors promote metastasis under physiological flow conditions14, 27.  
Furthermore, AMD3100, a specific inhibitor of CXCR4 signaling26, when applied to the 
endothelium can significantly reduce adhesion of cancer cells not expressing CXCR4 
(Fig. 2c, d).  Taken together, these data suggest that inhibiting chemokine receptors on 
endothelial cells may be of equal or greater importance for preventing initial steps of 




While we have focused on circulating cancer cells, this microfluidic system is a 
versatile platform for studying other intravascular processes, such as trafficking and 
adhesion of immune cells under physiological or pathological conditions.  In addition, 
since the described system is rooted in microfabrication technology, we have established 
a system that can be parallelized for high-throughput experiments.  By combining the 
convenience and cost-effectiveness of in vitro cell culture with key physical, cellular, and 
molecular components of the in vivo vasculature, we expect this new technology will 
accelerate studies of the intravascular microenvironment in metastatic cancer and 
development of new therapies to block this key step in metastasis. 
Methods 
Device fabrication.  The microfluidic device (Fig. IV.1a) consisted of two channel layers 
of 12:1 base to curing agent poly(dimethylsiloxane) (PDMS, Sylgard 184, Dow Corning) 
that sandwiched a semi-porous, optically clear polyester membrane28.  The layers were 
sealed together using a very thin (~10 μm) and uniform PDMS/toluene glue that provided 
robust, leakage-free sealing29.  The top and bottom PDMS layers were molded as 
previously described28 except the top layer featured a funnel –shaped inlet that was 
molded to intersect the inlet of the top channel (Fig. IV.1a).   After the device was 
assembled, tubing was attached to the outlet of the top channel and to the inlets of the 
bottom channels using epoxy.  Subsequently, the devices were treated with plasma 
oxygen (SPI Supplies, West Chester, PA) for 10 min to reduce hydrophobicity of 
surfaces.  Immediately afterwards, the top channel was coated with a fibronectin solution 
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(10 μg/ml PBS, 3h, 37oC).  Prior to cell seeding, the device was sterilized by placing 
under UV light for ~ 30 min.   
 
Endothelial cell culture and seeding.  Human dermal microvascular cells (HDMECs, 
Lonza) passage numbers 6-8 were cultured in EBM-2 + 5% FBS + SingleQuot® kit 
(supplements such as VEGF, bFGF, etc) or EGM-2 MV (Lonza).  A concentrated 
solution of HDMECs (~107 cells/ml EGM-2 MV) were loaded into the funnel-shaped, 
allowed to attach along the entire length of the top channel, and grown to confluence (24-
48 h after seeding).   
 
CXCR7 and CXCR4 expression in MDA-MB-231 human breast cancer cells.  
Human MDA-MB-231 breast cancer cells (ATCC) were cultured in DMEM + 10% FBS 
+ 1% L-glutamine + 0.5% penicillin/streptomycin.  Lentiviral vectors for CXCR4-GFP, 
CXCR7, or GFP control (Fig.3) were used to stably transduce MDA-MB-231 cells to 
create the described 231-CXCR4, 231-CXCR7, or 231-control cells respectively.  
Chemokine receptor expression in the 231-CXCR4, 231-CXCR7 cells, and 231-control 
cells were verified by flow cytometry (Fig. IV.3a). 
 
RT-PCR.  Endothelial cells were cultured in EBM-2 + Single®Quots with TNF-α (50 
ng/ml), CXCL12 (100 ng/ml), or vehicle control for 5 hours.  Total RNA was prepared 
using Trizol reagent (Invitrogen) according to the manufacturer’s protocol.  RNA was 
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purified further over an RNA extraction column (Qiagen), including on-column treatment 
with DNaseI.  RT-PCR was performed using a two-step kit (ThermoScript, Invitrogen).  
Sequences of PCR primers were the following: 






GAPDH: 5’-GAAGGTGAAGGTCGGAGT-3’ and 5’-
GAAGATGGTGATGGGATTTC-3’ 
 
Western Blot.  231 breast cancer cells were cultured overnight in DMEM medium 
containing 0.5% serum.  Breast cancer cells then were treated with 100 ng/ml CXCL12 
(R&D Systems) for 3 or 10 minutes, respectively.  Human dermal microvascular 
endothelial cells were cultured in EBM-2 + Single®Quots and treated with 100 ng/ml 
CXCL12 for 10 minutes or 5 hours, respectively.  Total cell lysates were harvested and 
prepared for Western blotting as described previously30.  Primary antibodies to AKT 
phosphorylated at serine 473 and total AKT (Cell Signaling) were used at 1:500 dilution, 
and a secondary anti-rabbit antibody conjugated with horseradish peroxidase was used at 
1:2000 dilution. Western blots were developed with ECL reagent (Amersham).       
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Calculation of shear stress levels.  The shear stress levels on the cells within the 






τ     (1) 
Where τ is the shear stress on the cells, μ is the viscosity of the fluid (water = 0.01 
dyn/cm2), Q2-D is the flow rate per width in the system and h is the height of the channel.  
This equation is valid for cases where the width is much larger than the height.  In our 
system, the height of the channels was 60 μm and the width was 800 μm. 
 
Flow-based intravascular adhesion experiments.  Prior to each experiment, the EGM-2 
MV culture in the funnel-inlet of the microfludic device was removed, washed with PBS, 
and replaced with EBM-2 + Single®Quots.  Subsequently, the top channel was washed 
with EBM-2 + Single®Quots by gravity flow.  Concurrently, the bottom channels were 
triple washed with PBS and replaced with either EBM-2 + Single®Quots (untreated) or 
EBM-2 +Single®Quots + cytokine or chemokine of interest (treated).  The flow in the 
top channel was stopped and the device was left to be treated for 5 h.  Concurrently, 
culture flasks of the 231 breast cancer cells were washed with PBS and serum starved in 
EBM-2 + 0.5% FBS for 5 h as well.  After serum starvation, the breast cancer cells were 
collected using citric saline, a calcium ion chelator, instead of trypsin to ensure cell 
surface proteins remain intact.  The cancer cells were centrifuged twice and resuspended 
in EBM-2 + 0.5% FBS at a concentration of 2 x 106 cells/ml).  The cancer cell suspension 
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was loaded into the funnel-shaped inlet.  Flow was controlled using a programmable 
syringe pump that withdraws fluid away from the funnel-shaped inlet at flow rates 
corresponding with either 0.50 dyn/cm2 or 2.50 dyn/cm2.  The microfluidic device was 
placed on the stage of an epi-fluorescence, inverted microscope (Nikon, TE-300).  The 
duration of each experiment was 30 min with images were recorded every 3 min and 
movies 1 min in duration recorded every 10 min.  For the 0.50 dyn/cm2 experiments, the 
top channel was washed for 1 min at shear stress levels of 8 dyn/cm2.  To determine cell 
counts, fluorescent cells in the entire compartment were counted blindly and treated as 
one data point. 
 
Statistical analysis.  Sample populations were compared either pairwise using the Mann-
Whitney U test or in groups of more than two using the Kruskal-Wallis test.  These tests 
are nonparametric and do not require an underlying normal distribution.  p < 0.05 was the 




Figure IV.1:  Microfluidic vasculature device enabling compartment specific 
activation of endothelium. 
 
(a) Schematic of the poly(dimethysiloxane) (PDMS) microfluidic device 
demonstrating multi-layer fabrication with a thin, porous polyester membrane 
sandwiched by the top and bottom PDMS layers. 
(b) Photograph of the microfluidic device loaded with different colored dye to 
distinguish between the top channel and the two bottom channels. 
(c) Top view of the microfluidic device.  During flow-based experiments, fluid is 
withdrawn away from the funnel-shaped inlet and through the top channel with a 
programmable syringe pump (see Methods).   
(d) Validation of region-specific stimulation of endothelium.  The upstream and 
downstream lower channels were filled with 25 μM Syto 64, a fluorescent dye 
that stains cells.  HDMECs overlying the upstream and downstream bottom 
channels, but not HDMECs in the middle of the channel fluoresce.  Fluorescence 
was evident within 15 minutes, remained spatially-restricted for at least 5.5 hours, 
and persisted after 30 minutes of flow through the top channel.  Image shows 5.5 
hours after initial treatment.  Scale bar represents 800 μm. 
(e) Phase contrast image of HDMECs cultured in the microfluidic device.  The image 
depicts the entire length of the endothelium with the upstream, middle, and 
downstream compartments clearly demarcated from each other.  Scale bar 
represents 800 μm.      
(f) Representative fluorescent images of adhesion of 231-control cells (stably 
expressing GFP) onto region-specific TNF-α treated endothelium under 0.50 
dyn/cm2 shear stress flow conditions.  In these images, the downstream 
compartment was treated with TNF-α (50 ng/ml for 5h) and denoted in the image 
with a ‘+’ while the upstream and middle compartments were left untreated.  
Scale bar represents 200 μm. 
(g) Quantitative analysis of 231-control cell adhesion under 0.50 dyn/cm2 shear stress 
flow conditions.  The inflammatory cytokine TNF-α  was applied to either the 
upstream or downstream compartment (denoted by a ‘+’) while the other 
compartment in the same device was left untreated.  Significantly greater numbers 
of cells adhered to the TNF-α treated compartment versus the untreated 
compartment (p < 0.01) (n = 3 each for upstream or downstream treated 
conditions). 
(h) Quantitative analysis of 231-control cell adhesion under 2.50 dyn/cm2 shear stress 
flow conditions.  TNF-α was applied to either the upstream or downstream 
compartment (denoted by a ‘+’) with the other compartments in the same device 
left untreated.  Cancer cell adhesion in the TNF-α treated compartment was 
significantly greater than the untreated compartment (p < 0.01) (n = 3 each for 
upstream or downstream treated conditions.    Data are expressed as the mean + 





Figure IV.2:  Region selective treatment of the microfluidic endothelium with 
combinations of cytokines and inhibitors under two different flow conditions.   
 
(a) Chemokine receptor expression in HDMECs determined by reverse transcription 
PCR (RT-PCR).  HDMECs show expression of CXCR4 but not CXCR7 under 
basal conditions.  CXCL12 upregulates CXCR4 but not CXCR7.  TNF-
α upregulates CXCR4 and results in expression of CXCR7.  RT-PCR for the 
housekeeping gene GAPDH confirms equivalent loading and intact RNA for all 
samples. 
(b) CXCL12 activates AKT in endothelium.  HDMECs were incubated with 100 
ng/ml CXCL12 for 10 minutes or 5 hours.  Control cells were incubated with 
BSA alone.  Cell lysates were probed for phosphorylation of serine 473, and then 
blots were stripped and re-probed for total AKT.  There is CXCL12-dependent 
activation of AKT that remains greater than control endothelium through 5 hours. 
(c) 231-control cancer cell adhesion onto endothelium treated with different 
combinations of CXCL12 (100 ng/ml), TNF-α (50 ng/ml), and the CXCR4 
inhibitor AMD3100 (80 ng/ml) for 5 hours under 0.50 dyn/cm2 flow conditions.  
Each of the treated compartments (left four columns) was matched by color and 
with its corresponding untreated compartment (right four columns).   Cell 
adhesion onto each treated compartment was compared to its corresponding 
untreated compartment (*, p < 0.05).  Comparing the five treated compartments, 
the levels of adhesion were statistically different (**, p < 0.05).  Conversely, for 
the untreated compartments, the levels of adhesion were statistically the same (#, 
p = 0.85).  AMD3100 in the presence of CXCL12 decreased adhesion by 34% 
relative to the CXCL12 only condition.  AMD3100 in the presence of CXCL12 
and TNF-α decreased adhesion 42% relative to CXCL12 + TNF-α.  ***, p < 0.05.  
n = 4-6 for each condition. 
(d) Same as (c) except under 2.50 dyn/cm2 flow conditions.  (*, p < 0.05; **, p < 




Figure IV.3: CXCL12 stimulated endothelium enhances adhesion of breast cancer 
cells. 
 
(a) Flow cytometry with antibodies to CXCR4 (12G5) or CXCR7 (11G8) shows 
expression in appropriate cell lines and absence of these receptors in pSico control 
cells.  Open symbol, isotype antibody control; filled yellow, antibody stain. 
(b) CXCL12-dependent activation of AKT in 231-CXCR4 cells.  Breast cancer cell 
lines were cultured overnight in medium containing 0.5% serum and then treated 
with 100 ng/ml CXCL12.  Cell lysates were probed for phosphorylation of AKT 
at serine 473.  Blots then were stripped and probed for total AKT as a loading 
control 
(c) Compartmentalized adhesion of 231-CXCR4, 231-CXCR7, and 231-control 
cancer cells onto CXCL12 treated versus untreated endothelium under 0.50 
dyn/cm2 shear flow conditions.  For all three cancer cell-types, the level of 
adhesion onto the CXCL12 treated endothelial compartment was significantly 
greater than onto the corresponding untreated compartment (*, p < 0.05).  The 
level of adhesion of the three different cancer cell-types was statistically different 
on both the CXCL12 treated and untreated endothelial compartments (**, p < 
0.01).  Data are expressed as mean + SEM.  n = 6 for all three cell-types.   
(d) Boxplot representing the ratio of the levels of adhesion of cancer cells onto the 
CXCL12 treated endothelial compartment over the untreated compartment.  
Adhesion to CXCL12-stimulated endothelium was enhanced to a comparable 
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Figure IV.4:  MDA-MB-231 human breast cancer cells transduced with CXCR4 or 
CXCR7.  Schematic diagram of lentiviral constructs.  CMV, cytomegalovirus immediate 
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Conclusion and Future Work 
 
 
Development of in vitro-based systems that properly model the mechanical and 
chemical environments of endothelial cells is necessary for advancing the understanding 
of vascular biology and medicine.  This dissertation research contributed to the field of 
vascular biology by utilizing a microfluidic and microfabrication approach in improving 
upon the current state of the art of conventional in vitro-based systems.  Microfluidic 
systems provide the capabilities to properly mimic the mechanical and chemical 
environments of endothelial cells at the proper length scales.1  Herein we provide a 
framework for highly integrated microfluidic devices which show promise for basic 
biomedical research.2  Finally, since the described systems are rooted in microfabrication 
technology, we have established systems that not only create more in vivo-like 
environments but can also be further parallelized for high-throughput experiments.   
 
In Chapter II we describe a computer-controlled micro-pumping and valving 
system for endothelial cell culture and shearing under pulsatile flow.3  By varying both 
the pumping frequency and the volume displacement per pumping stroke, we can deliver 
a broad range of shear stress levels to confluent monolayers of endothelial.  This range of 
shear stress includes levels seen in the arterial vasculature4 (~ 10 dyn/cm2) which we 
show align and elongate endothelial cells.  The novel aspects of this design include:  1) 
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multiple separate endothelial cell compartments enabling multiple cell shearing 
experiments in parallel and 2) a self-contained system (i.e. no external pumping system 
and reservoirs) which limits consumption of reagents and potential for contamination.  
The system described in Chapter II marks a significant step in creating a microfluidic-
based platform capable of providing greater insights into the mechanisms involved with 
mechanotransduction of endothelial cells. 
 
In Chapter III, we provided a practical solution to the problems with evaporation 
that are commonly seen in PDMS microfluidic systems.  Continuous culture of cells 
under sub-microliter amounts of fluid is highly desired in microfluidic systems but is 
virtually impossible in PDMS microfluidic systems because of the material’s high gas 
permeability.5   We constructed a PDMS-parylene-PDMS “hybrid” membrane that 
dramatically reduced evaporation-mediated shifts in osmolality that are very detrimental 
to cell viability.  By integrating the “hybrid” membrane, we were able to utilize our 
microfluidic pumping and valving system introduced in Chapter II to continuously 
culture endothelial cells while recirculating approximately 1 nl of fluid per cell for ~12 h.  
Furthermore, we properly buffered the culture media and adapted the pumping and 
valving system onto a customized stage for an inverted microscope to observe changes in 
endothelial cells in real-time.  Consequently, we created and observed nutrient-limited 
conditions with recirculation that mimic conditions such as ischemia due to stroke6 which 
is not readily achieved with macroscopic model systems.  Combined with the described 
dynamic pumping and valving system, we establish a microfluidic system that could be 
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used to dynamically switch from recirculation culture to perfusion culture with fresh 
media to accurately mimic ischemia-reperfusion injury following stroke.   
 
The results described in Chapter IV were obtained by utilizing a 
compartmentalized microfluidic endothelium that allowed for region-specific stimulation.  
We modelled the intravascular adhesion of cancer cells that initiates metastasis at 
secondary sites.7   Research on the vascular microenvironment has been hindered by 
challenges in studying this compartment in metastasis under conditions that reproduce in 
vivo physiology while allowing facile experimental manipulation.  Using the microfluidic 
vasculature  system, we produced selective stimulation with CXCL12, a chemokine 
strongly implicated in metastasis8-11 and established that activated endothelial cells confer 
site-specific adhesion of circulating cancer cells independent of CXCR4 or CXCR7 
receptors on tumor cells.  This unique combination of microfluidic technology with 
cancer biology provides a unique physiologic system to reproduce the intravascular 
microenvironment in metastasis and elucidate new cellular and molecular targets for 
cancer therapy.  
 
One of the dominant driving forces behind the development of mammalian cell-
based microfluidic (or “animal-on-a-chip”) systems is to bridge the gap that currently 
exists between conventional static cell culture assays and animal studies.  Animal-on-a-
chip systems possess physiologically relevant complexity (e.g. flow) not present in 
conventional cell culture systems yet are far simpler to use than animal models.12  As a 
result, it is believed that the effectiveness and toxicity of a drug compound will be easier 
 70
to spot with animal-on-chip systems than with conventional model systems.13  Because of 
these attributes, animal-on-a-chip systems are of wide interest from both biologists and 
pharmaceutical companies.  The work presented in this dissertation in recreating the 
vasculature in microfluidic systems and can be seen as steps towards the development of 
“blood vessels-on-a-chip” for studying both the biology and the response of drugs 
involved with vascular diseases. 
   
The described work represents an advancement of in vitro-based systems for 
evaluating the response of endothelial cells to shear stress and the role of the vasculature 
in breast cancer metastasis.  Despite these advances, the described systems possess 
certain limitations that may be addressed with future research.  In Chapter II, the time-
averaged shear stress levels generated in the described microfluidic system was 0-10 
dyn/cm2.  In the arterial vasculature, the time-averaged shear stress levels ranges from 5-
20 dyn/cm2.14  Thus, the system described in Chapter II is capable of the lower end of 
shear stress levels that is considered physiologically relevant but not the higher end.  To 
achieve time-averaged shear stress levels greater than 10 dyn/cm2, multiple large 
displacement pumps in parallel can be used to actuate fluid through a single channel.  
Furthermore, activating multiple pumps for a single channel would provide more 
versatility in the types of pulsatile flow profiles that could be generated and characterized 
to model the different flow profiles present in the vasculature of different parts of the 
body.4   
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The system described in Chapter III is capable of recirculation culture of 
endothelial cells by utilizing a novel and dynamic Braille-based pumping and valving 
scheme.  However, to fully model the conditions present in ischemia following stroke, it 
is necessary to combine recirculation culture with acute hypoxic conditions.6  It is 
challenging to achieve physiologically meaningful hypoxia in PDMS-based microfluidic 
systems in large part due to PDMS’s high permeability and solubility to oxygen.15  To 
address the current limitations of the system described in Chapter III in achieving 
hypoxia, it is probably necessary that the microfluidic device be composed of a reduced 
ratio of PDMS and an increased ratio of gas impermeable materials such as parylene or 
glass.  However, it would be ideal that despite integration with gas impermeable 
materials that the microfluidic device would be compatible with the described Braille-
based pumping and valving system because with Braille, the capabilities are already in 
place for dynamic switching from recirculation to perfusion culture to model ischemia-
reperfusion injury in a manner not possible with conventional model systems. 
 
One of the strengths of microfluidic systems is the ability to recreate 
physiological conditions more faithfully than conventional static-based systems.16  
However, an underlying limitation of current microfluidic systems is the lack of 
integration of readily quantifiable and biologically meaningful measurement capabilities.2, 
17  For instance, the biological measurements that were made within microfluidic devices 
that were described in this dissertation were changes in cell morphology (Chapter II), cell 
survival (Chapter III), and cell adhesion (Chapter IV).  Although these measurements 
provided invaluable insight with regard to their respective studies, these measurements on 
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their own are not capable of elucidating the molecular mechanisms occurring either 
intracellularly or extracellularly that are of great importance in understanding the 
underlying biology.  In order for cell-based microfluidic systems to be more widely 
adopted by cell biologists, these systems must not only integrate rudimentary biological 
measurements and assays but the commonly used molecular-based measurements and 
assays in a user-friendly manner.  This particular problem is not a simple one to answer 
but is of such great importance to our field that it should be addressed with time, effort, 
and ingenuity.  Once microfluidics becomes widely adopted by cell biologists, the 
volume of meaningful biological information obtained using microfluidic systems will be 
sure to increase dramatically. 
 
The goals of future work that would build off the research presented in this 
dissertation could be focused in five different directions:  1) enhanced parallelization for 
increased throughput, 2) improved materials and fabrication processes, 3) escalated 
biological complexity to more faithfully model in vivo conditions, 4) improved 
integration of biological assays on chip, and 5) improved user-friendliness for biologists 
and clinicians to support translatable research.  These five directions are not mutually 
exclusive of each other and can be investigated in combination with each other.  If given 
the opportunity to directly advance the research presented in this dissertation, I would 
probably focus on directions 3) and 4).  This dissertation research has focused primarily 
in designing and validating new platforms for studying vascular biology.  It would be 
enjoyable to implement these platforms to advance the understanding of certain 
biological processes which can be accomplished once increasing both the biological 
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complexity and the ability to measure biology in these systems.  Furthermore, successful 
implementation of directions 3) and 4) would strongly help validate the utility of 
microfluidic systems to biologists and potentially help them in the development of their 
own research.   
 
Collectively, the results presented in this dissertation confirm that microfluidic 
technology can be used to properly mimic a broad range of the endothelial cell 
environments seen in physiology that may govern certain vascular diseases.  Microfluidic 
systems possess the capabilities of precise fluid actuation,18 formation of independent 
cellular compartments for parallel experiments,19 and spatial control and delivery of 
biomolecules.20  The work in this dissertation describes integration of these unique 
features of microfluidic systems and adapting them for endothelial cell culture.  By doing 
so, we establish that microfluidic systems have the capabilities of advancing the 
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